
The free Patent Expiration Bulletin is your vehicle to reach a targeted pharmaceutical industry audience. Subscribers include:
The bulletin is sent to more than 11,300 opt-in readers every week, resulting in tens of thousands of monthly exposures. It is your opportunity to reach your audience by permission marketing; direct to their inboxes.
See a
sample newsletter (opens in new window)
Contact admin@DrugPatentWatch.com
for more information or to place an insertion order.
Copyright © 2002-2013 thinkBiotech LLC. ISSN: 2162-2639
`abc